Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MYL5 |
| Upstream (Parents) |
|---|
| (<<) ARHGEF2 → MYL5 |
| (<<) BCL2L1 → MYL5 |
| (<<) CDK5 → MYL5 |
| (<<) GRHPR → MYL5 |
| (<<) GRPEL1 → MYL5 |
| (<<) HSPA9 → MYL5 |
| (<<) KLF7 → MYL5 |
| (<<) LOC441204 → MYL5 |
| (<<) LYAR → MYL5 |
| (<<) LYPD5 → MYL5 |
| (<<) MKNK2 → MYL5 |
| (<<) MT3 → MYL5 |
| (<<) NCOR1 → MYL5 |
| (<<) RASA1 → MYL5 |
| (<<) RHOV → MYL5 |
| (<<) RRP9 → MYL5 |
| (<<) RXRA → MYL5 |
| (<<) SH3GLB2 → MYL5 |
| (<<) SULT1A1 → MYL5 |
| Downstream (Children) |
|---|
| MYL5 → CXADR (>>) |
| MYL5 → IL1RN (>>) |
| MYL5 → MAP3K1 (>>) |
| MYL5 → NOTCH4 (>>) |
